Detailed price information for Living Cell Technologies Ltd (LVCLF) from The Globe and Mail including charting and trades.

Citius Oncology, Inc. (NASDAQ: CTOR) and its 92%‑owned Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) recently signed a ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Vermont passes law banning student cell phone use in schools to curb distractions and mental health concerns. Debate ensues ...

Let’s start with what the company actually does. Ballard designs and manufactures hydrogen fuel cell systems used in buses, ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

We expect investors to focus on the sales performance of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other pipeline updates when the company reports its second-quarter 2025 results.

Much has been written about the incredible story of the science and the parallel story of bringing the law, regulations and public on this journey and it’s an impressive tale. What I want to focus on ...

A recent study reveals that aging isn't linear but accelerates around age 50, impacting blood vessels and adrenal glands ...

Incyte Corporation INCY reported second-quarter 2025 adjusted earnings of $1.57 per share, which beat the Zacks Consensus ...

Over at Chardan Capital, Geulah Livshits reiterated a buy rating and a $25 price target on July 23. From the stock's price of ...

July 31, 2025) - Signature Resources Ltd. (TSXV: SGU) (OTCQB: SGGTF) (FSE: 3S30) ("Signature" or the "Company") is pleased to ...